U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
18911891Pilot RCT to Test Effectiveness of the ACE4 (Activity Challenge- 4 Areas) for Depression and AnxietyRecruitingNo Results AvailableAnxiety Disorder; Mixed With Depression (Mild)Behavioral: ACE4https://ClinicalTrials.gov/show/NCT02538549
18921892A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNo Results AvailableIdiopathic Pulmonary Fibrosis (IPF)Drug: PBI4050https://ClinicalTrials.gov/show/NCT02538536
18931893[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT02538523
18941894Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer and Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by SurgeryNot yet recruitingNo Results AvailableHead and Neck Squamous Cell Carcinoma|Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma|Recurrent Nasopharynx Carcinoma|Recurrent Salivary Gland Carcinoma|Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary|Stage III Nasal Other: Laboratory Biomarker Analysis|Biological: Pembrolizumab|Drug: Vorinostathttps://ClinicalTrials.gov/show/NCT02538510
18951895Northern Babies: A Study of Predictors of Postpartum Depression and Parent-infant Interaction DifficultiesNot yet recruitingNo Results AvailableDepression, PostpartumBehavioral: The Newborn Behavioral Observation (NBO)|Behavioral: Routine carehttps://ClinicalTrials.gov/show/NCT02538497
18961896Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese SubjectsNot yet recruitingNo Results AvailableBreast CancerDrug: Letrozole|Dietary Supplement: Fish Oilhttps://ClinicalTrials.gov/show/NCT02538484
18971897LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerRadiation: Radiation therapy|Drug: Study Drughttps://ClinicalTrials.gov/show/NCT02538471
18981898Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized InfantsRecruitingNo Results AvailableBronchiolitisDrug: 3 % hypertonic saline up to 72H|Drug: 3 % hypertonic saline up to 24Hhttps://ClinicalTrials.gov/show/NCT02538458
18991899Can we Forget? Directed Forgetting and Embodied Cognition in SchizophreniaCompletedNo Results AvailableSchizophreniaOther: Memorization of the verbs by miming the action|Other: Memorization of the verbs by imagining the action|Other: Memorization of the action verbs by means of another word|Other: Simple memorization of the verbshttps://ClinicalTrials.gov/show/NCT02538445
19001900Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid TumorsNot yet recruitingNo Results AvailableProstate Cancer|Non-Small Cell Lung Cancer|Breast CancerDrug: RQ-00000007|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT02538432
19011901Group-based Peer Support Versus Individual Education for Patients Undergoing CPAP TreatmentNot yet recruitingNo Results AvailableSleep Apnea, ObstructiveBehavioral: Peer Support|Behavioral: Individual Educationhttps://ClinicalTrials.gov/show/NCT02538419
19021902The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate.RecruitingNo Results AvailableAdenomatous Polyp of ColonOther: Segmental withdrawalhttps://ClinicalTrials.gov/show/NCT02538406
19031903Relative Bioavailability of Sorafenib Tablet for Oral SuspensionNot yet recruitingNo Results AvailableBiological AvailabilityDrug: Sorafenib (BAY43-9006)|Drug: Sorafenib (BAY43-9006)|Drug: Sorafenib (BAY43-9006)|Drug: Sorafenib (Nexavar, BAY43-9006)https://ClinicalTrials.gov/show/NCT02538393
19041904EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer PatientsRecruitingNo Results AvailableSuspected Left Adrenal Gland Metastasis in Lung CancerProcedure: EUS-B-FNA followed by EUS-FNA for LAG analysishttps://ClinicalTrials.gov/show/NCT02538380
19051905Trial of YH12852 in Healthy Subjects and Patients With Functional ConstipationRecruitingNo Results AvailableFunctional ConstipationDrug: YH12852 IR(Immediate Release) 0.3mg|Drug: YH12852 IR(Immediate Release) 0.5mg|Drug: YH12852 IR(Immediate Release) 1mg|Drug: YH12852 IR(Immediate Release) 2mg|Drug: YH12852 IR(Immediate Release) 3mg|Drug: Prucalopride 2mg|Drug: Placebo|Drug: YH12852 DR(Delayed Release)1 4mg|Drug: YH12852 DR(Delayed Release)2 8mg|Drug: YH12852 DR(Delayed Release)1 2mg|Drug: YH12852 DR(Delayed Release)2 4mghttps://ClinicalTrials.gov/show/NCT02538367
19061906The Effect of Riboflavin in Crohn's DiseaseNot yet recruitingNo Results AvailableCrohn DiseaseDietary Supplement: Riboflavin supplementationhttps://ClinicalTrials.gov/show/NCT02538354
19071907Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)Not yet recruitingNo Results AvailableRheumatoid Arthritis|Inflammatory Arthritis|Arthritis|Psoriatic Arthritis|Psoriasis|Ankylosing Spondylitis|Enteropathic Arthritis|Crohn's DiseaseBiological: Herpes Zoster Vaccine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02538341
19081908Comparison of Harmonic Scalpel and Ligasure Devices in Laparoscopic Morbid Obesity SurgeryCompletedNo Results AvailableMorbid ObesityDevice: Harmonic scapel|Device: Ligasurehttps://ClinicalTrials.gov/show/NCT02538328
19091909Using 3,4-dihydroxy-6-[18F]-Fluoro-l-phenylalanine ( [18F]FDOPA) PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease PatientsNot yet recruitingNo Results AvailableParkinson`s DiseaseProcedure: Implantations of fetal dopaminergic grafthttps://ClinicalTrials.gov/show/NCT02538315
19101910Minirin Versus Oxybutynin for Nocturnal Enuresis in ChildrenCompletedNo Results AvailableNocturnal EnuresisDrug: Minirin|Drug: Oxybutyninhttps://ClinicalTrials.gov/show/NCT02538302
19111911Hospital Without Dyspnea. Rationale and Design of a Multidisciplinary InterventionNot yet recruitingNo Results AvailableDyspneaBehavioral: Teaching talkshttps://ClinicalTrials.gov/show/NCT02538289
19121912Carotid Endarterectomy and Carotid Artery Stenting in BrazilRecruitingNo Results AvailableArterial Diseases, Carotidhttps://ClinicalTrials.gov/show/NCT02538276
19131913Volume-targeted Versus Pressure-limited Noninvasive Ventilation in Patients With Acute Hypercapnic Respiratory FailureCompletedNo Results AvailableAcute Hypercapnic Respiratory FailureDevice: Volume-targeted noninvasive ventilationhttps://ClinicalTrials.gov/show/NCT02538263
19141914Acceptability Study on Oral Nutrition Supplement (ONS)RecruitingNo Results AvailableOral Nutritional SupplementationDietary Supplement: Nutricomp Drink Plushttps://ClinicalTrials.gov/show/NCT02538250
19151915the Effect of Sub-gingival Irrigation With Ibuprofen 2% Mouthwash in Treatment of Periodontal Diseases.CompletedNo Results AvailablePeriodontitisDrug: placebo|Drug: Ibuprofen 2% mouthwashhttps://ClinicalTrials.gov/show/NCT02538237
19161916Efficacy of Subgingivally Delivered Doxycycline Plus Ketoprofen Gel as an Adjunct to Non-surgical Periodontal TreatmentCompletedNo Results AvailableChronic PeriodontitisDrug: 2.5%ketoprofen gel + 3 % doxycycline|Drug: :2.5%ketoprofen gelhttps://ClinicalTrials.gov/show/NCT02538224
19171917The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune ResponsesRecruitingNo Results AvailableRotavirus Infections|Intestinal Bacteria Flora Disturbance|Reaction - Vaccine Nos|Tetanus|Streptococcal PneumoniaBiological: Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccinehttps://ClinicalTrials.gov/show/NCT02538211
19181918Lenalidomide Maintenance in Plasma Cell MyelomaRecruitingNo Results AvailableMultiple Myeloma|Plasma Cell MyelomaDrug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT02538198
19191919Intradermal Rabies Immunization Using NanoJect: A Comparative StudyCompletedNo Results AvailableIntradermal (ID) Vaccination DeviceDevice: NanoJect device (DebioJect™)|Device: Classical syringe (1mL Becton Dickinson (BD) Luer-Lock™) with a 25 Guage (G) needle (Terumo® Neolus)|Device: Classical syringe (1mL BD Luer-Lock™) with a 22G needle (Terumo® Neolus)|Drug: Vaccin rabique Pasteur®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02538185
19201920Cell-mediated Immunity for Prevention of CMV DiseaseNot yet recruitingNo Results AvailableCytomegalovirus InfectionsOther: T-Track® CMV assayhttps://ClinicalTrials.gov/show/NCT02538172

* Görseller ve İçerik tekif hakkına sahip olabilir